UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS
Effective Date: November 18, 2022
Form: S-3
CIK: 0001840233
Company Name: Xilio Therapeutics, Inc.
File Number: 333-268264
Xilio Therapeutics (NASDAQ:XLO)
Historical Stock Chart
From May 2023 to Jun 2023 Click Here for more Xilio Therapeutics Charts.
Xilio Therapeutics (NASDAQ:XLO)
Historical Stock Chart
From Jun 2022 to Jun 2023 Click Here for more Xilio Therapeutics Charts.